TY - JOUR
T1 - Quality indicators for the care and outcomes of adults with atrial fibrillation
AU - Arbelo, Elena
AU - Aktaa, Suleman
AU - Bollmann, Andreas
AU - D'Avila, André
AU - Drossart, Inga
AU - Dwight, Jeremy
AU - Hills, Mellanie True
AU - Hindricks, Gerhard
AU - Kusumoto, Fred M.
AU - Lane, Deirdre A.
AU - Lau, Dennis H.
AU - Lettino, Maddalena
AU - Lip, Gregory Y.H.
AU - Lobban, Trudie
AU - Pak, Hui Nam
AU - Potpara, Tatjana
AU - Saenz, Luis C.
AU - Van Gelder, Isabelle C.
AU - Varosy, Paul
AU - Gale, Chris P.
AU - Dagres, Nikolaos
AU - Boveda, Serge
AU - Deneke, Thomas
AU - Defaye, Pascal
AU - Conte, Giulio
AU - Lenarczyk, Radoslaw
AU - Providencia, Rui
AU - Guerra, Jose M.
AU - Takahashi, Yoshihide
AU - Pisani, Cristiano
AU - Nava, Santiago
AU - Sarkozy, Andrea
AU - Glotzer, Taya V.
AU - Oliveira, Mario Martins
N1 - Publisher Copyright:
© 2020 Published on behalf of the European Society of Cardiology. All rights reserved.
PY - 2021/4
Y1 - 2021/4
N2 - Aims: To develop quality indicators (QIs) that may be used to evaluate the quality of care and outcomes for adults with atrial fibrillation (AF). Methods and results: We followed the ESC methodology for QI development. This methodology involved (i) the identification of the domains of AF care for the diagnosis and management of AF (by a group of experts including members of the ESC Clinical Practice Guidelines Task Force for AF); (ii) the construction of candidate QIs (including a systematic review of the literature); and (iii) the selection of the final set of QIs (using a modified Delphi method). Six domains of care for the diagnosis and management of AF were identified: (i) Patient assessment (baseline and follow-up), (ii) Anticoagulation therapy, (iii) Rate control strategy, (iv) Rhythm control strategy, (v) Risk factor management, and (vi) Outcomes measures, including patient-reported outcome measures (PROMs). In total, 17 main and 17 secondary QIs, which covered all six domains of care for the diagnosis and management of AF, were selected. The outcome domain included measures on the consequences and treatment of AF, as well as PROMs. Conclusion: This document defines six domains of AF care (patient assessment, anticoagulation, rate control, rhythm control, risk factor management, and outcomes), and provides 17 main and 17 secondary QIs for the diagnosis and management of AF. It is anticipated that implementation of these QIs will improve the quality of AF care.
AB - Aims: To develop quality indicators (QIs) that may be used to evaluate the quality of care and outcomes for adults with atrial fibrillation (AF). Methods and results: We followed the ESC methodology for QI development. This methodology involved (i) the identification of the domains of AF care for the diagnosis and management of AF (by a group of experts including members of the ESC Clinical Practice Guidelines Task Force for AF); (ii) the construction of candidate QIs (including a systematic review of the literature); and (iii) the selection of the final set of QIs (using a modified Delphi method). Six domains of care for the diagnosis and management of AF were identified: (i) Patient assessment (baseline and follow-up), (ii) Anticoagulation therapy, (iii) Rate control strategy, (iv) Rhythm control strategy, (v) Risk factor management, and (vi) Outcomes measures, including patient-reported outcome measures (PROMs). In total, 17 main and 17 secondary QIs, which covered all six domains of care for the diagnosis and management of AF, were selected. The outcome domain included measures on the consequences and treatment of AF, as well as PROMs. Conclusion: This document defines six domains of AF care (patient assessment, anticoagulation, rate control, rhythm control, risk factor management, and outcomes), and provides 17 main and 17 secondary QIs for the diagnosis and management of AF. It is anticipated that implementation of these QIs will improve the quality of AF care.
UR - http://www.scopus.com/inward/record.url?scp=85094129928&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=85094129928&partnerID=8YFLogxK
U2 - 10.1093/europace/euaa253
DO - 10.1093/europace/euaa253
M3 - Article
C2 - 32860039
AN - SCOPUS:85094129928
SN - 1099-5129
VL - 23
SP - 494
EP - 495
JO - Europace
JF - Europace
IS - 4
ER -